Saphenous Vein

• 

  Subject Areas on Research

  • 1985: left thoracotomy for reoperative coronary artery bypass procedures. 1993 update. 
  • A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts. 
  • A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia. 
  • A mouse bleeding model to study oral anticoagulants. 
  • A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. 
  • A1-A2 interposition grafting for surgical treatment of a giant "unclippable" A1 segment aneurysm. 
  • Absence of metabolite formation during nitroglycerin-induced relaxation of isolated blood vessels. 
  • Activation of pp60c-src is necessary for human vascular smooth muscle cell migration. 
  • Acute results, complications, and effect of lesion characteristics on outcome with the solid-state, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium:YAG Laser Multicenter Investigators. 
  • Adeno-associated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transduction. 
  • Alternative conduits for coronary revascularization: a novel approach for harvest of the lesser saphenous vein. 
  • Aneurysm of a saphenous vein bypass graft associated with aneurysms of native coronary arteries. 
  • Angiographic changes in vein grafts: stable surrogate or seductive siren? 
  • Arterial reconstruction for radial artery occlusion. 
  • Assessment of myocardial perfusion during CABG surgery with two-dimensional transesophageal contrast echocardiography. 
  • Balloon occlusion femoral angiography prior to in-situ saphenous vein bypass. 
  • Blood vessels engineered from human cells. 
  • Brachial artery reconstruction using the heparin-bonded Sundt shunt. 
  • C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. 
  • Case 6--1996, Traumatic aortocoronary saphenous vein graft occlusion. 
  • Clinical and angiographic assessment of complex mammary artery bypass grafting. 
  • Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. 
  • Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions. 
  • Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts. 
  • Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt. 
  • Combined TMR and mitral valve replacement via left thoracotomy. 
  • Combined rotational and directional atherectomy guided by intravascular ultrasound in an occluded vein graft. 
  • Complete and incomplete revascularization at aortocoronary bypass surgery: experience with 392 consecutive patients. 
  • Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. 
  • Correction of a saphenous vein graft to coronary vein anastamosis by selective retrograde coil-induced occlusion to arterialize the native vein. 
  • Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. 
  • Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial. 
  • Economic impact of new interventional therapies: are we asking the right questions? 
  • Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. 
  • Effect of subintimal resection on initial outcome and restenosis for native coronary lesions and saphenous vein graft disease treated by directional coronary atherectomy. A report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. 
  • Effects of pulsatile perfusion on human saphenous vein vasoreactivity: a preliminary report. 
  • Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. 
  • Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. 
  • Endoscopic versus open saphenous vein harvest: the effect on postoperative outcomes. 
  • Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. 
  • Enlarging pseudoaneurysm of a right saphenous vein graft after emergent coronary artery bypass grafting. 
  • Evidence summary of combined saphenous ablation and treatment of varicosities versus staged phlebectomy. 
  • Expanding the role of endovenous laser therapy: results in large diameter saphenous, small saphenous, and anterior accessory veins. 
  • Factors that influence perforator vein closure rates using radiofrequency ablation, laser ablation, or foam sclerotherapy. 
  • Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. 
  • Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia. 
  • Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. 
  • Genetic variants associated with vein graft stenosis after coronary artery bypass grafting. 
  • Great saphenous vein stump thrombosis after harvesting for coronary artery bypass graft surgery. 
  • Homocysteine as a risk factor of restenosis after carotid endarterectomy. 
  • Hypercoagulability affecting early vein graft patency does not exist after off-pump coronary artery bypass. 
  • Iatrogenic Arteriovenous Fistula With Associated Pseudoaneurysm of Posterior Tibial Artery After Revision Total Ankle Arthroplasty: A Case Report. 
  • Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft. 
  • Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters. 
  • Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators. 
  • Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery. 
  • Intracellular calcium transients are necessary for platelet-derived growth factor but not extracellular matrix protein-induced vascular smooth muscle cell migration. 
  • Intraoperative perfusion contrast echocardiography. Initial experience during coronary artery bypass grafting. 
  • Investigations into the role of sulfhydryl groups in the mechanism of action of the nitrates. 
  • Ipsilateral free fibula transfer for reconstruction of a segmental femoral-shaft defect. 
  • LDH isoenzymes and myocardial infarction in patients undergoing coronary bypass surgery: an excellent correlation. 
  • Leiomyosarcoma of the splenic vein. 
  • Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. 
  • Long-term outcomes of the symmetry vein graft anastomosis device: a matched case-control analysis. 
  • Long-term results of endoscopic versus open saphenous vein harvest for lower extremity bypass. 
  • Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. 
  • Measurement of vascular input impedance in infrainguinal vein grafts. 
  • Mechanochemical ablation for symptomatic great saphenous vein reflux: A two-year follow-up. 
  • Mechanochemical ablation in patients with chronic venous disease: a prospective multicenter report. 
  • Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts. 
  • Mycotic Saccular Abdominal Aortic Aneurysm in an Infant after Cardiac Catheterization: A Case Report. 
  • Non-vena cava venous leiomyosarcomas: a review of the literature. 
  • Noninvasive assessment of the effects of aorta-coronary bypass grafting on ventricular function during rest and exercise. 
  • Novel vascular effects of isoprenaline following pacing-induced heart failure in the dog. 
  • Options in the management of varicose veins, 2008. 
  • Outcomes of Saphenous Vein Graft Intervention With and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis. 
  • Outcomes of carotid-subclavian bypass performed in the setting of thoracic endovascular aortic repair. 
  • Pacing-induced heart failure in the dog: evaluation of peripheral vascular alpha-adrenoceptor subtypes. 
  • Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. 
  • Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent. 
  • Peripheral nerve vein wrapping for intractable lower extremity pain. 
  • Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. 
  • Popliteal artery aneurysms: a 25-year surgical experience. 
  • Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial. 
  • Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry. 
  • Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention. 
  • Preoperative assessment of left ventricular function in patients selected for direct myocardial revascularization. 
  • Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues. 
  • Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventions. 
  • Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. 
  • Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial. 
  • Reduction in wound morbidity rates following endoscopic saphenous vein harvest. 
  • Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. 
  • Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. 
  • Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Renal artery aneurysm in a solitary kidney: successful surgical repair. 
  • Renovascular disease in children and adolescents. 
  • Response by Latif et al to Letter Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial". 
  • Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial". 
  • Response to Letters Regarding Article, "Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV". 
  • Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate. 
  • Right thoracotomy for reoperative right coronary artery bypass procedures. 
  • Risk factors in coronary artery bypass surgery. 
  • Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. 
  • Ruptured Salmonella mycotic aneurysm of the extracranial carotid artery. 
  • Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009). 
  • Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program. 
  • Salvage of advanced squamous cell carcinomas of the head and neck: internal carotid artery sacrifice and extracranial-intracranial revascularization. 
  • Saphenous vein graft disease: a left main equivalent. 
  • Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. 
  • Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. 
  • Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery? 
  • Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. 
  • Saphenous vein versus polytetrafluoroethylene carotid patch angioplasty. 
  • Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study. 
  • Spontaneous rupture of a carotid artery aneurysm. 
  • Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. 
  • Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial. 
  • Subclavian vein to right atrial appendage bypass without sternotomy to maintain arteriovenous access in patients with complete central vein occlusion, a new approach. 
  • Successful aneurysm resection and coronary artery revascularization following saphenous vein graft aneurysm rupture. 
  • Successful revascularization for delayed presentation of radiation-induced distal upper extremity ischemia. 
  • Surgeon judgment and utility of transit time flow probes in coronary artery bypass grafting surgery. 
  • Temporal alterations in peripheral vascular responsiveness during both the development and recovery from pacing-induced heart failure. 
  • The Preservation and Handling of Vein Grafts in Current Surgical Practice: Findings of a Survey Among Cardiovascular Surgeons of Top-Ranked US Hospitals. 
  • The influence of time on the response to dopamine after coronary artery bypass grafting: assessment of left ventricular performance and contractility using pressure/dimension analyses. 
  • The role of integrins in saphenous vein vascular smooth muscle cell migration. 
  • Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. 
  • Tolerance to organic nitrates: clinical and experimental perspectives. 
  • Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: a multicenter experience. 
  • Transluminal extraction coronary atherectomy. 
  • Ultrasound assessment of left ventricular function following aortocoronary saphenous vein bypass grafting. 
  • Update on radiofrequency ablation. 
  • Vascular smooth muscle responsiveness to noradrenaline and phenylephrine following experimental heart failure in dogs. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery